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Toll-like receptors (TLRs) are important components of in-
nate immunity.We investigated the association betweenpoly-
morphisms in the TLR2, TLR4, and TLR9 genes and suscepti-
bility to noninvasive forms of pulmonary aspergillosis. A
significant association was observed between allele G on
Asp299Gly (TLR4) and chronic cavitary pulmonary aspergil-
losis (odds ratio [OR], 3.46; P  .003). Susceptibility to aller-
gic bronchopulmonary aspergillosiswas associatedwith allele
C on T-1237C (TLR9) (OR, 2.49; P  .043). No particular
polymorphism was associated with severe asthma with fungal
sensitization. These findings reinforce the importance of in-
nate immunity in the pathogenesis of different forms of
aspergillosis.
Aspergillus fumigatus is themost prevalent airborne, filamentous
fungal pathogen in humans. It is the main cause of aspergillosis,
a condition that can manifest as invasive, allergic, and chronic
noninvasive syndromes. Allergic bronchopulmonary aspergillo-
sis (ABPA) is an allergic hypersensitivity to bronchial coloniza-
tion by Aspergillus species, which affects mainly patients with
asthma and patients with cystic fibrosis. A severe asthma pheno-
type associated with fungal sensitization (SAFS) can also de-
velop. In contrast, chronic cavitary pulmonary aspergillosis
(CCPA) is a subacute and slowly destructive form of pulmonary
aspergillosis.
Although the immunological status of the host is probably the
main determinant of the clinical presentation of aspergillosis,
very little is known about this subject. Recently, considerable
attention has been focused on innate immunity, the first line of
defense that ultimately activates the adaptive immune system
through specific signals. The latest evidence has focused on pro-
teins that belong to the collectin family, including the lung sur-
factant protein (SP), mannose-binding lectin (MBL), and pen-
traxin 3 (PTX3). Allele variants in a gene encoding SP-A have
been associated with increased susceptibility to both ABPA and
CCPA [1]. Also, distinct MBL genotypes have been linked with
CCPA [1, 2], and an intronic polymorphism in the MBL gene
was found to underlie elevated levels of MBL and greater disease
severity in ABPA patients [3]. On the other hand, PTX3 was
shown to play a role in resistance to Aspergillus, and PTX3-null
mice showed increased susceptibility to invasive pulmonary as-
pergillosis [4].
Toll-like receptors (TLRs) are important components of the
innate immune system. TLRs are transmembrane proteins char-
acterized by an extracellular domain containing leucine-rich re-
peats (LRR) and a cytoplasmic Toll/interleukin-1 receptor (TIR)
domain, which activates common signaling pathways. TLRsme-
diate the recognition of microbial challenges and subsequent
inflammatory responses through rapid changes in the expres-
sion of genes encoding cytokines and inflammatory molecules.
More specifically, TLR-2 and TLR-4 have been implicated as
important components of the initial host immune response to
fungal pathogens, both yeasts and molds [5].
Several variations in TLR genes have been studied, including
that of Asp299Gly (A896G) in the TLR4 gene. This results in
an amino acid change in the LRRdomain of TLR-4, impairing its
recognition ability. This single-nucleotide polymorphism (SNP)
has been correlated with diminished airway response to inhaled
lipopolysaccharide in healthy individuals. On the other hand,
the Arg753Gln (G2258A) polymorphism, which affects the
TIR domain of TLR-2, impairs signal transduction and its func-
tional activity. Another SNP, T-1237C, located within the puta-
tive promoter of the TLR9 gene has been implicated in chronic
inflammatory diseases including asthma [6] and Crohn disease.
Moreover, TLRs have also been associated with several patho-
logical conditions affecting the lungs. Thus, due to the signifi-
cance of innate immunity in host defense, genetic variations in
the genes of this system could have a major impact on immune
responses to Aspergillus infections.
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In the present population-based, case-control study, we
aimed to explore the contribution made by polymorphisms in
the TLR2, TLR4, and TLR9 genes to susceptibility to different
forms of aspergillosis, namely CCPA, ABPA, and SAFS.
Materials and Methods. The study population comprised
76 patients; males and females were equally distributed. Mean
age (SD) was 57.6 ( 11.8) years. The main diagnoses were
CCPA (n  40), ABPA (n  22), and SAFS (n  14). These
individuals were recruited from a cohort of patients attending
South Manchester University Hospitals NHS Trust for
Aspergillus-related diseases. Eighty unrelated healthy individuals
of identical ethnicity were included as controls. Informed writ-
ten consent was obtained from all participants.
The clinical definitions were as follows. CCPA was diagnosed
in the presence of the following symptoms and/or results: (1)
chronic pulmonary or systemic symptoms with exclusion of
other pulmonary pathogens, (2) radiological evidence of pro-
gressive pulmonary lesions with surrounding inflammation
(with or without an intracavitary mass), (3) precipitating (IgG)
antibody to Aspergillus in the serum, and (4) persistently ele-
vated inflammatory markers in the serum.
The diagnostic criteria for ABPA included the following
symptoms and/or results: (1) asthma, (2) total serum IgE levels
1000 IU/mL, (3) elevated A. fumigatus–specific serum IgE lev-
els, (4) precipitating antibodies toA. fumigatus in the serum (not
always present in patients with long-standing ABPA), and (5)
central bronchiectasis. The minor diagnostic criteria for ABPA
were as follows: peripheral blood eosinophilia (often absent in
patients on steroids), repeated detection of Aspergillus in spu-
tum, expectoration of brown plugs or flecks, and history of re-
current pulmonary infiltrates (transient or fixed).
The diagnosis of SAFS was made on the basis of the following
recently proposed criteria [7]: (1) severe asthma, (2) total IgE
levels 1,000 IU/mL, and (3) positive skin-prick test and/or
raised specific IgE toA. fumigatus.We included in this study only
SAFS patients who reacted to A. fumigatus. In contrast to pa-
tients with ABPA, patients with SAFS usually do not give a his-
tory of productive cough containing mucus plugs and infre-
quently have positive sputum cultures for fungi.
Genotype determination of polymorphisms in TLR2
(Arg753Gln; SNP id: rs5743708), TLR4 (Asp299Gly; SNP id:
rs4986790), and TLR9 (T-1237C; SNP id: rs5743836) genes was
performed by use of bidirectional PCR amplification of specific
alleles (Bi-PASA), as described elsewhere [8]. Details about the
primers used in this study are shown in table 1.
The Fisher exact test and Pearson2 test were used to compare
allele frequencies between patient groups and controls. Consis-
tency of genotype frequencies with the Hardy–Weinberg equi-
librium was tested using a 2 test on a contingency table of ob-
served vs. predicted genotype frequencies. 2 values, odds ratios
(ORs), and P values were calculated with 95% confidence inter-
vals.
Results. TLR polymorphisms in the control population
were characterized as follows. Of the 80 control patients studied,
5 of 80 (6.2%), 10 of 80 (12.5%), and 15 of 80 (18.8%) patients
were heterozygous for Arg753Gln (G/A), Asp299Gly (A/G), and
Table 1. Polymerase chain reaction primers used to analyze polymorphisms in Toll-like receptor (TLR) 2,
TLR4, and TLR9 genes by use of Bi-PASA genotyping.
Target gene,
single-nucleotide
polymorphism Primer sequence (5'33')
Primer
concentration,
mol/L DNA fragment sizes, bp
TLR2 PQ,524;PW,399;MQ,152
Arg753Gln
P: CTCCAGGCCAAAAGGAAGC 0.1
Q: AAAGATCCCAACTAGACAAAGA 0.1
W: ggcggcgggggccTGTTCATTATCTTCC 0.1
M: gggccgggggTTCTGCAAGCTGCA 0.1
TLR4 PQ,644;PW,455;MQ,220
Asp299Gly
P: AGAACTTAATGTGGCTCACAAT 0.1
Q: GAAAAAGCATTCCCACCTTTG 0.4
W: ggcggcgggggccTTAAATAAGTCAATAATAT 0.4
M: gggccgggggTACTACCTCGATGG 0.4
TLR9 PQ,644;PW,395;MQ,275
T-1237C
P: TCATTCAGCCTTCACTCAGA 0.4
Q: CACATTCAGCCCCTAGAGGG 0.05
W: ggcggcgggggccTGCTGTTCCCTCTGCCTGA 0.05
M: gggccgggggccATGAGACTTGGGGGAGTTTC 0.05
NOTE. P, left outer primer; Q, right outer primer; W, inner wild-type primer; M, inner mutant primer.
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T-1237C (T/C) polymorphisms, respectively. In addition, no
homozygous mutation was observed in controls (i.e., A/A for
Arg753Gln, G/G for Asp299Gly, or C/C for T-1237C). The dis-
tribution of genotypes did not deviate from those predicted by
the Hardy-Weinberg equilibrium.
There was no significant difference between patients with
ABPA and control patients with respect to allele frequencies or
genotype distribution of the TLR2 and TLR4 polymorphisms
(table 2). The G/A genotype in TLR2 was not detected in any
patient with ABPA. Although patients with ABPA had a lower
frequency of the G allele in TLR4, compared with control pa-
tients (2.3% vs. 6.3%), this difference did not reach statistical
significance (P  .463). Patients with ABPA had a significantly
higher frequency of allele C for the T-1237C SNP in TLR9 than
control patients (20.5% vs. 9.4%; P  .043; OR, 2.49).
The frequency of allele A for the TLR2 polymorphism among
patients with SAFS was more than twice that observed among
control patients (7.1% vs. 3.1%), although this difference was
not statistically significant (P  .280). No difference was ob-
served regarding the TLR4 variation between patients with SAFS
and control patients; both presented similar allele frequencies.
Patients with SAFS had a lower frequency of allele C in the TLR9
gene, although this difference was nonsignificant in comparison
with control patients (3.6% vs. 9.4%; P  .474). When patients
with SAFS andABPAwere considered together and compared to
control patients, no difference in allele frequency in the TLR
genes was observed (data not shown).
Patients with CCPA demonstrated a statistically significant
higher frequency of allele G in the TLR4 gene, compared with
controls (18.8% vs. 6.3%;OR, 3.46; P  .003). The frequency of
SNPs in the TLR2 and TLR9 genes was similar for patients with
CCPA and control patients.
Discussion. TLR-4 is among the major receptors involved
in the recognition of pathogenic fungi and the initiation of the
inflammatory response. Wang et al. [9] proposed TLR-4 as the
main receptor for Aspergillus hyphae, because monoclonal anti-
bodies directed against CD-14 and TLR-4 partially inhibited
TNF- release fromhumanmonocytes stimulated byA. fumiga-
tus hyphae. Accordingly, TLR-4–deficient mice have shown in-
creased susceptibility to A. fumigatus infection. Netea et al. [10]
showed that macrophages from TLR-4–deficient mice pro-
duced less TNF- and IL-1 than did macrophages from control
mice upon stimulation with A. fumigatus conidia but not with
hyphae. These data suggest that TLR-4–mediated signals might
be lost during Aspergillus germination, therefore suggesting that
this phenotypic switching might be a mechanism to escape the
immune system. Interestingly, we found the Asp299Gly poly-
morphism (TLR4) to be highly associated with CCPA (OR, 3.46;
P  .01). This SNP had not been previously observed to be as-
sociated with acute invasive aspergillosis [11]. Because its pres-
ence does not ultimately affect signal transduction and cytokine
production inmononuclear cells challengedwithA. fumigatus, a
putative mechanism for disease association would be an abnor-
mal TLR-4 extracellular domain, which hampered its function
by disruptingmicrobial recognition. Patients with CCPA appear
to have multiple defective immune responses, of which this may
be one in a minority of patients. On the other hand, allele G on
Asp299Gly (TLR4) was slightly less frequent in ABPA patients.
This is perhaps unexpected, as it has been shown to be protective
in hyperinflammatory states, such as atherosclerosis, by dimin-
Table 2. Distribution of genotypes and allele frequencies of the studied polymorphisms in Toll-like receptor (TLR) 2, TLR4, and TLR9
genes in study and control patients.
Gene,
single-nucleotide
polymorphism
Study
group (n)
No. (% frequency)
2 P OR (95% CI)Genotype Allele
TLR2, Arg753Gln G/G G/A A/A G A
Controls (80) 75 (93.8) 5 (6.2) 0 (0.0) 155 (96.9) 5 (3.1)
ABPA (22) 22 (100) 0 (0.0) 0 (0.0) 44 (100.0) 0 (0.0) 1.41 0.587 1.032 (1.004–1.061)
SAFS (14) 12 (85.7) 2 (14.3) 0 (0.0) 26 (92.9) 2 (7.1) 1.07 0.280 2.385 (0.439–12.944)
CCPA (40) 38 (95.0) 2 (5.0) 0 (0.0) 78 (97.5) 2 (2.5) 0.07 1.000 0.795 (0.151–4.190)
TLR4, Asp299Gly A/A A/G G/G A G
Controls (80) 70 (87.5) 10 (12.5) 0 (0.0) 150 (93.8) 10 (6.3)
ABPA (22) 21 (95.5) 1 (4.5) 0 (0.0) 43 (97.7) 1 (2.3) 1.07 0.463 0.349 (0.043–2.802)
SAFS (14) 12 (85.7) 2 (14.3) 0 (0.0) 26 (92.9) 2 (7.1) 0.03 0.695 1.154 (0.239–5.570)
CCPA (40) 25 (62.5) 15 (37.5) 0 (0.0) 65 (81.3) 15 (18.8) 8.93 0.003 3.462 (1.477–8.110)
TLR9, T-1237C T/T T/C C/C T C
Controls (80) 65 (81.2) 15 (18.8) 0 (0.0) 145 (90.6) 15 (9.4)
ABPA (22) 14 (63.6) 7 (31.8) 1 (4.54) 35 (79.5) 9 (20.5) 4.08 0.043 2.486 (1.005–6.145)
SAFS (14) 13 (92.9) 1 (7.1) 0 (0.0) 27 (96.4) 1 (3.6) 0.03 0.474 0.358 (0.045–2.825)
CCPA (40) 33 (82.5) 7 (17.5) 0 (0.0) 73 (91.3) 7 (8.8) 0.02 0.874 0.927 (0.362–2.373)
NOTE. ABPA, allergic bronchopulmonary aspergillosis; CCPA, chronic cavitary pulmonary aspergillosis; CI, confidence interval; OR, odds ratio; SAFS, severe
asthma with fungal sensitization. 2 and P values were calculated regarding allele frequencies.
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ishing the levels of proinflammatory cytokines [12]. The signif-
icance, if any, of this observation requires a study involving a
larger number of patients with ABPA for clarification.
We observed no association between TLR2 polymorphisms
and susceptibility to CCPA. Similar findings were previously de-
scribed for patients with invasive aspergillosis [11]. Interest-
ingly, the TLR2 SNP was not present in any patient with ABPA,
which could argue for a protective role against ABPA. It is curi-
ous in this regard that TLR-2–deficient mice are highly suscep-
tible to experimental ABPA (L. Romani, unpublished observa-
tions). Ultimately, the numbers in our study population were
too small to show any significant difference, suggesting at max-
imum a weak effect. For the same reason, one can speculate that
allele A in TLR2 might increase the risk for SAFS.
Also interesting was the association of ABPA with the TLR9
SNP (OR, 2.49; P  .05). TLR-9 is a receptor that detects un-
methylated CpGmotifs prevalent in bacterial and viral DNA. As
A. nidulans has been shown to be virtually devoid of genomic
cytosine methylation [13] (which is probably also true for A.
fumigatus), TLR9 activation by CpGmotifs may occur after lysis
of fungal cells during Aspergillus infections. However, the im-
portance of TLR9 in aspergillosis is still obscure. Although both
conidia and hyphae of A. fumigatus seem to signal through
TLR-9 on murine neutrophils [14], TLR-9–deficient mice
showed paradoxically greater conidiocidal activity and hyphal
damage than wild-type mice. In addition, TLR-9 has been asso-
ciated with anti-allergic activities. Accordingly, TLR9 SNP has
been associated with an increased risk of asthma [6], and TLR-9
agonists are under development for patients with asthma and
other allergic conditions. It remains to be elucidated if this con-
stitutes an independent risk factor for ABPA, since all ABPA
patients in our cohort were also diagnosed with asthma. In ad-
dition, work by Novak et al. [15] showed that the C allele of
T-1237C decreases TLR9 expression, which could also be pro-
posed as a feature underlying susceptibility to ABPA .
Due to the limited number of patients in the study, the im-
portance of the TLR2 SNP in patients with aspergillosis cannot
be underestimated, although its association with CCPA seems
statistically improbable. No polymorphism was associated with
the SAFS phenotype, reflecting either the limited number of pa-
tients, or more likely, different pathogenesis. Also, the impor-
tance of polymorphisms affecting other TLR genes (as well as
other SNPs in the TLRs investigated here) cannot be excluded.
Because multiple receptors appear to be involved in the recog-
nition of different components of Aspergillus, a better under-
standing of the signaling processes involved in innate immunity
is ultimately required.
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